BRAGGION, Marco
 Distribuzione geografica
Continente #
NA - Nord America 354
AS - Asia 109
EU - Europa 67
SA - Sud America 25
AF - Africa 1
Totale 556
Nazione #
US - Stati Uniti d'America 345
SG - Singapore 45
CN - Cina 38
BR - Brasile 23
UA - Ucraina 17
HK - Hong Kong 10
DE - Germania 9
GB - Regno Unito 8
VN - Vietnam 6
IT - Italia 5
RU - Federazione Russa 5
AT - Austria 4
FI - Finlandia 4
IE - Irlanda 4
SE - Svezia 4
TR - Turchia 4
CA - Canada 3
CR - Costa Rica 2
IN - India 2
LT - Lituania 2
MX - Messico 2
PL - Polonia 2
AR - Argentina 1
AZ - Azerbaigian 1
BH - Bahrain 1
EC - Ecuador 1
ES - Italia 1
FR - Francia 1
JM - Giamaica 1
JO - Giordania 1
MD - Moldavia 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 556
Città #
Fairfield 56
Ashburn 40
Seattle 30
Houston 27
Singapore 25
Woodbridge 23
Cambridge 19
Wilmington 18
Jacksonville 17
Beijing 15
New York 14
Chandler 10
Hong Kong 10
Princeton 8
Ann Arbor 7
Nanjing 5
São Paulo 5
Changsha 4
Dallas 4
Dublin 4
Ho Chi Minh City 4
London 4
Los Angeles 4
Des Moines 3
Helsinki 3
Istanbul 3
Moscow 3
Redondo Beach 3
San Diego 3
Stockholm 3
Boardman 2
Boston 2
Coyoacán 2
Jinan 2
Montreal 2
Orem 2
San José 2
The Dalles 2
Vienna 2
Warsaw 2
Alvorada 1
Amman 1
Armação dos Búzios 1
Arouca 1
Baku 1
Belgorod 1
Belo Horizonte 1
Brescia 1
Brusque 1
Buffalo 1
Campos dos Goytacazes 1
Charlotte 1
Chennai 1
Chisinau 1
Columbus 1
Dagenham 1
Dianópolis 1
Elkin 1
Eunápolis 1
Florianópolis 1
Formiga 1
Hamad Town 1
Hangzhou 1
Hải Dương 1
Islington 1
Itapevi 1
Jeddah 1
Jipijapa 1
Johannesburg 1
Kingston 1
Lappeenranta 1
Miami 1
Mossoró 1
Mumbai 1
Ningbo 1
Northampton 1
Nuremberg 1
Osasco 1
Ourinhos 1
Pedro II 1
Phoenix 1
Praia Grande 1
Riverside 1
Rockford 1
Rome 1
Salto 1
San Francisco 1
San Miguel de Tucumán 1
Shanghai 1
Shenyang 1
Shijiazhuang 1
Strasbourg 1
Taizhou 1
Toronto 1
Tucson 1
Uberaba 1
Veneto 1
Vĩnh Long 1
Wuxi 1
Totale 453
Nome #
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 177
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 159
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 143
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial 81
Totale 560
Categoria #
all - tutte 2.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 6 1 11 6 20 9 5
2021/202231 3 4 2 2 0 3 1 3 0 2 4 7
2022/202342 4 0 2 2 4 7 0 2 9 0 5 7
2023/202432 1 0 2 2 0 10 0 1 8 1 0 7
2024/202571 0 0 0 11 6 8 3 3 8 1 20 11
2025/2026122 18 19 21 40 21 3 0 0 0 0 0 0
Totale 560